Keeping Up With Biosimilars

(B5) Biosimilars in Vision: Addressing Drug Trends and Managed Care Strategies

Thursday, March 23, 2023

2:45 PM – 4:00 PM

Location: 302AB

ACPE UAN:0233-0000-23-017-L01-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Prerakkumar Parikh, PharmD

Director, Specialty Clinical Solutions
Magellan Rx Management
San Jose, CA
Sneha Sharma, PharmD

Director, Specialty Clinical Solutions
Magellan Rx Management
Albuquerque, NM

Moderator(s)

JG

Jeremy Garris, BS Pharmacy

VP Clinical Solutions
Exponent Health
Louisville, Kentucky

As treatment options continue to expand for highly prevalent eye disorders such as age-related macular degeneration (AMD) and diabetic macular edema (DME), it is essential to stay up to date with novel agents and biosimilars in the ophthalmic category. This session will include an overview of the anti-VEGF drugs used for ophthalmic conditions, focusing on their utilization trends and management strategies. Additionally, the faculty will discuss the management of interchangeable biosimilars from a medical benefit perspective. Join this session to learn about current drug trends, clinical strategies, and the robust pipeline in the biosimilars ophthalmic space.

Learning Objectives::

At the completion of this activity, participants should be able to:

Explain current medical drug trends in the ophthalmic space.
Outline payer management strategies for anti-VEGF drugs.
Discuss challenges that health plans face with interchangeable biosimilars and propose solutions.
Identify ophthalmic drugs in the pipeline and their cost impacts.